These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 7522176

  • 1. Inhibition of human platelets and polymorphonuclear neutrophils by the potent and metabolically stable prostaglandin D2 analog ZK 118.182.
    Darius H, Michael-Hepp J, Thierauch KH, Fisch A.
    Eur J Pharmacol; 1994 Jun 13; 258(3):207-13. PubMed ID: 7522176
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils.
    Bleasdale JE, Thakur NR, Gremban RS, Bundy GL, Fitzpatrick FA, Smith RJ, Bunting S.
    J Pharmacol Exp Ther; 1990 Nov 13; 255(2):756-68. PubMed ID: 2147038
    [Abstract] [Full Text] [Related]

  • 5. Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptor.
    Merritt JE, Hallam TJ, Brown AM, Boyfield I, Cooper DG, Hickey DM, Jaxa-Chamiec AA, Kaumann AJ, Keen M, Kelly E.
    Br J Pharmacol; 1991 Jan 13; 102(1):251-9. PubMed ID: 1710526
    [Abstract] [Full Text] [Related]

  • 6. Stimulation of prostaglandin D2 receptors on human platelets by analogs of prostacyclin.
    Alvarez R, Eglen RM, Chang LF, Bruno JJ, Artis DR, Kluge AF, Whiting RL.
    Prostaglandins; 1991 Aug 13; 42(2):105-19. PubMed ID: 1775633
    [Abstract] [Full Text] [Related]

  • 7. SQ-27986 inhibition of platelet aggregation is mediated through activation of platelet prostaglandin D2 receptors.
    Seiler S, Brassard CL, Federici ME.
    Prostaglandins; 1990 Aug 13; 40(2):119-30. PubMed ID: 2171039
    [Abstract] [Full Text] [Related]

  • 8. Stable 9 beta- or 11 alpha-halogen-15-cyclohexyl-prostaglandins with high affinity to the PGD2-receptor.
    Thierauch KH, Stürzebecher CS, Schillinger E, Rehwinkel H, Radüchel B, Skuballa W, Vorbrüggen H.
    Prostaglandins; 1988 Jun 13; 35(6):855-68. PubMed ID: 2847246
    [Abstract] [Full Text] [Related]

  • 9. Synergistic interaction of adenylate cyclase activators and nitric oxide donor SIN-1 on platelet cyclic AMP.
    Fisch A, Michael-Hepp J, Meyer J, Darius H.
    Eur J Pharmacol; 1995 May 26; 289(3):455-61. PubMed ID: 7556414
    [Abstract] [Full Text] [Related]

  • 10. ZK 110 841--a selective and potent prostaglandin D2 analogue.
    Thierauch KH, Stürzebecher S, Schillinger E, Schulz G, Radüchel B, Skuballa W, Vorbrüggen H, Schulze PE.
    Prog Clin Biol Res; 1989 May 26; 301():597-601. PubMed ID: 2798462
    [No Abstract] [Full Text] [Related]

  • 11. Cytotoxic enzyme release and oxygen centered radical formation in human neutrophils are selectively inhibited by E-type prostaglandins but not by PGI2.
    Hecker G, Ney P, Schrör K.
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Apr 26; 341(4):308-15. PubMed ID: 2159112
    [Abstract] [Full Text] [Related]

  • 12. Differential inhibition of human neutrophil activation by cyclosporins A, D, and H. Cyclosporin H is a potent and effective inhibitor of formyl peptide-induced superoxide formation.
    Wenzel-Seifert K, Grünbaum L, Seifert R.
    J Immunol; 1991 Sep 15; 147(6):1940-6. PubMed ID: 1653806
    [Abstract] [Full Text] [Related]

  • 13. Receptor-specific threshold effects of cyclic AMP are involved in the regulation of enzyme release and superoxide production from human neutrophils.
    Lad PM, Goldberg BJ, Smiley PA, Olson CV.
    Biochim Biophys Acta; 1985 Aug 30; 846(2):286-95. PubMed ID: 2411298
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of platelet function by polymorphonuclear leukocytes.
    Zatta A, Prosdocimi M, Bertelé V, Bazzoni G, Del Maschio A.
    J Lab Clin Med; 1990 Nov 30; 116(5):651-60. PubMed ID: 2146349
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Stimulus specificity of prostaglandin inhibition of rabbit polymorphonuclear leukocyte lysosomal enzyme release and superoxide anion production.
    Fantone JC, Marasco WA, Elgas LJ, Ward PA.
    Am J Pathol; 1984 Apr 30; 115(1):9-16. PubMed ID: 6324595
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Phenol red is a thromboxane A2/prostaglandin H2 receptor antagonist in canine lingual arteries and human platelets.
    Greenberg SS, Johns A, Kleha J, Xie J, Wang Y, Bianchi J, Conley K.
    J Pharmacol Exp Ther; 1994 Mar 30; 268(3):1352-61. PubMed ID: 8138950
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.